Debora Heller

Dr. Debora Heller

Universidade Cruzeiro do sul
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2014 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
PDF file
TLTalita Gomes Baêta Lourenço
Talita Gomes Baêta Lourenço
Debora HellerDebora Heller
Debora Heller
CSCarina Maciel Silva‐Boghossian
Carina Maciel Silva‐Boghossian
SCSean L. Cotton
Sean L. Cotton
BPBruce J. Paster
Bruce J. Paster
ACAna Paula Vieira Colombo
Ana Paula Vieira Colombo
Aim: To determine microbial profiles that discriminate periodontal health from different forms of periodontal diseases.Methods: Subgingival biofilm was obtained from patients with periodontal health (27), gingivitis (11), chronic periodontitis (35) and aggressive periodontitis (24), and analysed for the presence of >250 species/phylotypes using HOMIM. Microbial differences among groups were examined by Mann–Whitney U‐test. Regression analyses were performed to determine microbial risk indicators of disease.Results: Putative and potential new periodontal pathogens were more prevalent in subjects with periodontal diseases than periodontal health. Detection of Porphyromonas endodontalis/Porphyromonas spp. (OR 9.5 [1.2–73.1]) and Tannerella forsythia (OR 38.2 [3.2–450.6]), and absence of Neisseria polysaccharea (OR 0.004 [0–0.15]) and Prevotella denticola (OR 0.014 [0–0.49], p < 0.05) were risk indicators of periodontal disease. Presence of Aggregatibacter actinomycetemcomitans (OR 29.4 [3.4–176.5]), Cardiobacterium hominis (OR 14.9 [2.3–98.7]), Peptostreptococcaceae sp. (OR 35.9 [2.7–483.9]), P. alactolyticus (OR 31.3 [2.1–477.2]), and absence of Fretibacterium spp. (OR 0.024 [0.002–0.357]), Fusobacterium naviforme/Fusobacterium nucleatum ss vincentii (OR 0.015 [0.001–0.223]), Granulicatella adiacens/Granulicatella elegans (OR 0.013 [0.001–0.233], p < 0.05) were associated with aggressive periodontitis.Conclusion: There were specific microbial signatures of the subgingival biofilm that were able to distinguish between microbiomes of periodontal health and diseases. Such profiles may be used to establish risk of disease.

16 September 2020 in Journal of Dental Research
Verified
Journal Article
Open access
PDF file
LFL.L. Fernandes
L.L. Fernandes
VPV.B. Pacheco
V.B. Pacheco
LBLeandro Borges
Leandro Borges
HAH.K. Athwal
H.K. Athwal
FEF. de Paula Eduardo
F. de Paula Eduardo
Debora HellerDebora Heller
Debora Heller
This review presents literature that highlights saliva’s utility as a biofluid in the diagnosis and monitoring of COVID-19. A systematic search was performed in 5 electronic databases (PubMed, Embase, LILACS, Scopus, and Web of Science). Studies were eligible for inclusion if they assessed the potential diagnostic value and/or other discriminatory properties of biological markers in the saliva of patients with COVID-19. As of July 22, 2020, a total of 28 studies have investigated the presence of SARS-CoV-2 RNA in saliva. Several of those studies confirmed reliable detection of SARS-CoV-2 in the saliva of patients with COVID-19. Saliva offered sensitivity and specificity for SARS-CoV-2 detection comparable to that of the current standard of nasopharyngeal and throat swabs. However, the utility of saliva in diagnosing COVID-19 infection remains understudied. Clinical studies with larger patient populations that measure recordings at different stages during the disease are still necessary to confirm the accuracy of COVID-19 diagnosis with saliva. Nevertheless, the utility of saliva as a diagnostic tool opens the possibility of using rapid and less invasive diagnostic strategies by targeting bioanalytes rather than the pathogen.

15 March 2016 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
Debora HellerDebora Heller
Debora Heller
EHE. J. Helmerhorst
E. J. Helmerhorst
AGA. C. Gower
A. C. Gower
WSW. L. Siqueira
W. L. Siqueira
BPB. J. Paster
B. J. Paster
FOF. G. Oppenheim
F. G. Oppenheim
Although the mature dental biofilm composition is well studied, there is very little information on the earliest phase of in vivo tooth colonization. Progress in dental biofilm collection methodologies and techniques of large-scale microbial identification have made new studies in this field of oral biology feasible. The aim of this study was to characterize the temporal changes and diversity of the cultivable and noncultivable microbes in the early dental biofilm. Samples of early dental biofilm were collected from 11 healthy subjects at 0, 2, 4, and 6 h after removal of plaque and pellicle from tooth surfaces. With the semiquantitative Human Oral Microbiome Identification Microarray (HOMIM) technique, which is based on 16S rRNA sequence hybridizations, plaque samples were analyzed with the currently available 407 HOMIM microbial probes. This led to the identification of at least 92 species, with streptococci being the most abundant bacteria across all time points in all subjects. High-frequency detection was also made with Haemophilus parainfluenzae , Gemella haemolysans , Slackia exigua , and Rothia species. Abundance changes over time were noted for Streptococcus anginosus and Streptococcus intermedius ( P = 0.02), Streptococcus mitis bv. 2 ( P = 0.0002), Streptococcus oralis ( P = 0.0002), Streptococcus cluster I ( P = 0.003), G. haemolysans ( P = 0.0005), and Stenotrophomonas maltophilia ( P = 0.02). Among the currently uncultivable microbiota, eight phylotypes were detected in the early stages of biofilm formation, one belonging to the candidate bacterial division TM7, which has attracted attention due to its potential association with periodontal disease.

1 June 2021 in Heliyon
Verified
Journal Article
Open access
FEFernanda de Paula Eduardo
Fernanda de Paula Eduardo
LCLuciana Corrêa
Luciana Corrêa
Debora HellerDebora Heller
Debora Heller
CDCarlo Amorin Daep
Carlo Amorin Daep
CBCarlos Benitez
Carlos Benitez
LBLetícia Mello Bezinelli
Letícia Mello Bezinelli
The saliva of patients with COVID-19 has a high SARS-CoV-2 viral load. The risk of spreading the virus is high, and procedures for viral load reduction in the oral cavity are important. Little research to date has been performed on the effect of mouthwashes on the salivary SARS-CoV-2 viral load. This pilot randomized single-center clinical trial investigated whether three types of mouthwash with solutions containing either 0.075% cetylpyridinium chloride plus 0.28% zinc lactate (CPC + Zn), 1.5% hydrogen peroxide (HP), or 0.12% chlorhexidine gluconate (CHX) reduce the SARS-CoV-2 viral load in saliva at different time points. Sixty SARS-CoV-2-positive patients were recruited and randomly partitioned into a placebo (oral rinsing with distilled water) group and other groups according to the type of mouthwash. Saliva samples were collected from the participants before rinsing (T0), immediately after rinsing (T1), 30 min after rinsing (T2), and 60 min after rinsing (T3). The salivary SARS-CoV-2 viral load was measured by qRT-PCR assays. Rinsing with HP and CPC + Zn resulted in better reductions in viral load, with 15.8 ± 0.08- and 20.4 ± 3.7-fold reductions at T1, respectively. Although the CPC + Zn group maintained a 2.6 ± 0.1-fold reduction at T3, this trend was not observed for HP. HP mouthwash resulted in a significant reduction in the SARS-CoV-2 viral load up to 30 min after rinsing (6.5 ± 3.4). The CHX mouthwash significantly reduced the viral load at T1, T2, and T3 (2.1 ± 1.5-, 6.2 ± 3.8-, and 4.2 ± 2.4-fold reductions, respectively). In conclusion, mouthwash with CPC + Zinc and CHX resulted in significant reductions of the SARS-CoV-2 viral load in saliva up to 60 mins after rinsing, while HP mouthwash resulted in a significant reduction up to 30 mins after rinsing. Despite this transitory effect, these results encourage further studies and suggest that these products could be considered as risk-mitigation strategies for patients infected with SARS-CoV-2.

1 July 2012 in Archives of Oral Biology
Verified
Journal Article
Closed access
Debora HellerDebora Heller
Debora Heller
CSCarina Maciel Silva-Boghossian
Carina Maciel Silva-Boghossian
RSRenata Martins Do Souto
Renata Martins Do Souto
ACAna Paula Vieira Colombo
Ana Paula Vieira Colombo

8 February 2011 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
Debora HellerDebora Heller
Debora Heller
VVVictor M. Varela
Victor M. Varela
MSMayra Xavier e Silva-Senem
Mayra Xavier e Silva-Senem
MTMaria Cynesia B. Torres
Maria Cynesia B. Torres
EFEduardo Jorge Feres-Filho
Eduardo Jorge Feres-Filho
ACAna Paula Vieira Colombo
Ana Paula Vieira Colombo